Estrella Immunopharma(ESLA)
$0.33-0.05 (-12.89%)
ESLA
Estrella Immunopharma financials statements
$0.33
At close:-0.05 (-12.89%)
Estrella Immunopharma (ESLA) Income Statement
48 Followers
Estrella Immunopharma Income Statement
Last quarter (Q3 2026), Estrella Immunopharma's total revenue was $0.00. In Q3, Estrella Immunopharma's net income was $-7.38M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Jun 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 13.06M | $ 8.85M | $ 7.31M | $ 11.11M | $ 1.69M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -13.06M | $ -8.85M | $ -7.31M | $ -11.11M | $ -1.69M | |
| $ -13.06M | $ -8.85M | $ -7.31M | $ -11.11M | $ -1.69M | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -13.06M | $ -8.85M | $ -7.31M | $ -11.11M | $ -1.69M | |
| $ -13.06M | $ -8.85M | $ -7.31M | $ -11.11M | $ -1.69M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.35 | $ -0.24 | $ -0.21 | $ -0.32 | $ -0.05 |
| Diluted EPS | $ -0.35 | $ -0.24 | $ -0.21 | $ -0.32 | $ -0.05 |
| Weighted Average Shares Outstanding | 36.82M | 36.68M | 35.20M | 35.20M | 35.20M |
| Weighted Average Shares Outstanding (Diluted) | 36.82M | 36.68M | 35.20M | 35.20M | 35.20M |
Currency in USD

